SCHEMBL22904142

SCHEMBL22904142

O=C1Cc2cnn(Cc3ccccc3)c2C(=O)N1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 1/20 0.45
IDO1 P14902 1/20 0.42
RECQL P46063 1/20 0.41
TDP2 O95551 2/20 0.41
CASP3 P42574 1/20 0.41
CASP7 P55210 1/20 0.41
CASP9 P55211 1/20 0.41
CASP6 P55212 1/20 0.41
CASP8 Q14790 1/20 0.41
MAP3K14 Q99558 1/20 0.41
HSD17B10 Q99714 1/20 0.40
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
TSHR P16473 1/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HTR2C P28335 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17338762 0.71 AADAT (0.47) MAPTIDO1RECQLHSD17B10TSHR
SCHEMBL9038732 0.69 ALDH1A1 (0.53) MEN1KMT2AMAPTIDO1RECQL
SCHEMBL22904149 0.69 MAPT (0.47) MEN1KMT2AMAPTTDP2CASP3
SCHEMBL12783192 0.68 POLB (0.47) MEN1KMT2AMAPTIDO1DDB1
SCHEMBL4828802 0.67 RECQL (0.41) MAPTRECQLHSD17B10TSHRALDH1A1
SCHEMBL77739 0.66 KMT2A (0.73) MEN1KMT2AMAPTRECQLHSD17B10
SCHEMBL30020048 0.65 HSD17B10 (0.54) MAPTIDO1RECQLHSD17B10TSHR
SCHEMBL4828671 0.65 PSD (0.43) MEN1KMT2AMAPTIDO1RECQL
SCHEMBL29250802 0.63 RECQL (0.50) MEN1KMT2AMAPTRECQLHSD17B10
SCHEMBL21359663 0.63 KMT2A (1.00) MEN1KMT2AMAPTRECQLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011631-A1 FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-01-21 WO disclosed